NCT03177668View on ClinicalTrials.gov

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

February 5, 2020

Study Completion Date

February 5, 2020

Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG

YS110

Intravenous administration

Trial Locations (1)

Unknown

Research Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY